Prof. Dr. Ali Önder Yildirim Director Institute of Lung Health and Immunity (LHI) +49 89 3187 4037 Email me “Keeping the lung healthy is important for the overall well-being of us humans. Especially COVID-19 has made us realize how vital a healthy lung is for survival. We therefore want to turn…
more
Lung Epidemiology The research interest of our working group focus on the role of genetic, environmental and life-style factors including their interplay on lung health and function. The research interest of our working group focus on the role of genetic, environmental and life-style factors…
more
Dr. Mareike Lehmann LHI Group Leader “Lung Inflammaging” - Emmy Noether Research Group Leader "The Heterogeneity of Lung Aging and Regeneration +49 89 3187 4687 Email me "I want my work to ultimately impact patients´ lives, that is what drives me and my research." “I want my work to ultimately…
more
CPC (Munich University Hospital, Asklepios Fachkliniken, CPC bioArchive) jointly operate an outpatient unit to coordinate studies involving lung disease patients. Essential part is the clinical and molecular phenotyping of patient cohorts with lung diseases such as COPD, Asthma, interstitial lung…
more
the Institute of Lung health and Immunity at Helmholtz Munich explore the immunological mechanisms underlying chronic lung diseases such as COPD, lung fibrosis, asthma, lung cancer and the complications following lung transplantation. Their aim: Translating findings into preventative and therapeutic…
more
Lehmann Lab Lung Inflammaging The Lehmann Lab aims to understand how aging predisposes the lung to the development of chronic lung diseases such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). The Lehmann Lab aims to understand how aging predisposes the lung…
more
New hope regarding lung diseases Lung research at Helmholtz Munich has made some spectacular breakthroughs. They could pave the way for the therapy of serious diseases. Lung research at Helmholtz Munich has made some spectacular breakthroughs. They could pave the way for the therapy of serious…
more
PD Dr. habil. med. Claudia A. Staab-Weijnitz, Ph.D. Group Leader “Immune barrier in lung disease”, Institute of Lung Health and Immunity / Spokesperson Environmental Health and Lung Research School +49 89 3187 4681 Visit Email me “Collagen is the most abundant protein in the body, yet we know little…
more
Fibrosis (IPF) is a chronic and lethal fibroproliferative disease of the lung, with unknown etiology. IPF is characterized by progressive fibrosis and irreversible loss of lung function, with a median survival, or time to lung transplantation, of about 3 years after diagnosis. In many organs, innate…
more
Funk Lab Ageing & Environmental stress in lung disease The Funk laboratory aims to understand how ageing and environmental stress affect the homeostasis and regenerative capacity of the lung epithelium, thereby promoting chronic inflammatory diseases, such as COPD. Based on this, we want to identify…
more